| Company Name: |
BOC Sciences |
| Tel: |
+1-631-485-4226 |
| Email: |
inquiry@bocsci.com |
|
| | Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methyl-d3-sulfonio]-5'-deoxy-, inner salt Basic information |
| | Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methyl-d3-sulfonio]-5'-deoxy-, inner salt Chemical Properties |
| storage temp. | 4°C, protect from light, stored under nitrogen | | solubility | H2O : 50 mg/mL (124.55 mM; Need ultrasonic) | | form | Solid | | color | White to off-white |
| | Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methyl-d3-sulfonio]-5'-deoxy-, inner salt Usage And Synthesis |
| Uses | S-Adenosyl-L-methionine-d3 (S-Adenosyl methionine-d3) is the deuterated product of S-Adenosyl-L-methionine (HY-B0617). S-Adenosyl-L-methionine (S-Adenosyl methionine) is an orally active methyl group donor. S-Adenosyl-L-methionine is a dietary supplement with potent antidepressant effects. S-Adenosyl-L-methionine also has antiproliferative, proapoptotic and antimetastatic roles in cancers. S-Adenosyl-L-methionine has the potential for, cancer, liver disease and osteoarthritis research[1][2][3]. | | References | [1] G M Bressa. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14. DOI:10.1111/j.1600-0404.1994.tb05403.x
[2] Wadie I Najm, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004 Feb 26;5:6. DOI:10.1186/1471-2474-5-6
[3] Shelly C Lu, et al. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012 Oct;92(4):1515-42. DOI:10.1152/physrev.00047.2011 |
| | Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methyl-d3-sulfonio]-5'-deoxy-, inner salt Preparation Products And Raw materials |
|